drugset / Trial / NCT04910477

Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache

NCT04910477

Phase 3 Completed 90 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

In our study, we will compare a new route of nebulization for effectiveness between dexmedetomidine, neostigmine/atropine and saline placebo for females complained of postdural puncture headache (PDPH) after cesarean section.

Timeline

Start
2021-06-01
Primary completion
2021-09-01
Completion
2021-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 10 ug/kg Other
Subject Dexmedetomidine Other / unclassified 1 mg/kg Other
Subject Neostigmine Other / unclassified 20 ug/kg Other

Indications